Re: T cells that recognize HER2 receptor may prevent HER2+ bc recurrence
It isn't as simple as Agness implies. This particular vaccine is made from each individual's T cells. Those cells are collected via apheresis, treated and then injected back over the course of 6 weeks. They can't vaccinate everyone because there isn't the lab available to treat everyone's T cells. In fact, I've been accepted into the clinical trial but the lab can't take me at the moment because there isn't room. The lab can only treat so many women. There just isn't the lab space or the lab workers to accommodate any more.
|